论文部分内容阅读
目的 :分析探讨盐酸氨溴索注射液联合雾化吸入治疗急性加重期慢性阻塞性肺疾病的临床效果。方法 :选取我院2014年5月-2016年6月期间所收治的急性加重期慢性阻塞性肺疾病患者100例,将其随机分为研究组和对照组,各50例,两组患者入院以后均进行一系列常规治疗,研究组在此基础上施以盐酸氨溴索注射液联合雾化吸入治疗,对两组患者的治疗效果进行观察统计。结果:研究组患者的显效率以及总有效率分别为52.0%、92.0%,比对照组的32.0%、72.0%明显偏高,P<0.05,差异具有统计学意义。结论:盐酸氨溴索注射液联合雾化吸入治疗急性加重期慢性阻塞性肺疾病的临床效果显著,有助于患者的病情恢复,在临床上具有十分广阔的应用前景。
Objective: To analyze the clinical effect of ambroxol hydrochloride injection combined with atomization inhalation in the treatment of acute exacerbation chronic obstructive pulmonary disease. Methods: A total of 100 acute exacerbation chronic obstructive pulmonary disease patients were selected from May 2014 to June 2016 in our hospital. They were randomly divided into study group and control group, with 50 cases in each group. After admission, All patients underwent a series of routine treatments. On the basis of this, the study group was treated with Ambroxol Hydrochloride Injection combined with atomization inhalation to observe the therapeutic effect of the two groups of patients. Results: The effective rate and total effective rate of the study group were 52.0% and 92.0% respectively, significantly higher than that of the control group (32.0% and 72.0%, P <0.05). The difference was statistically significant. Conclusion: Ambroxol hydrochloride injection combined with atomization inhalation in the treatment of acute exacerbation of chronic obstructive pulmonary disease has a significant clinical effect, which is helpful to the patients’ recovery and has a very broad clinical application prospect.